Suchergebnisse - "Balar, Arjun V"

PubPharm (7)

1

PIVOT-10 : Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer

enthalten in: Future oncology (London, England) | 2021

von Huddart, R. | Siefker-Radtke, A. | Balar, A. | +15

2

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

enthalten in: Current oncology reports | 2019

von Lattanzi, M. | Balar, A.

3

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

enthalten in: Current oncology reports | 2019

von Lattanzi, M. | Balar, A.

4

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

enthalten in: Current oncology reports | 2019

von Lattanzi, M. | Balar, A.

5

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma : a report on the successful treatment of a rare malignancy

enthalten in: Journal for immunotherapy of cancer | 2018

von Lattanzi, M. | Deng, F. | Chiriboga, L. | +7

6

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

enthalten in: Journal for ImmunoTherapy of Cancer | 2018

von Lattanzi, M. | Deng, F. | Chiriboga, L. | +7

7

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

enthalten in: Journal for ImmunoTherapy of Cancer | 2018

von Lattanzi, M. | Deng, F. | Chiriboga, L. | +7

1
[1]